Mingwei Ma, MD

Ming-wei MA

Education
Peking University First Hospital, Beijing ,China Sept 2012- Sept 2015

Hebei Medical University, Hebei, China. Sept 2007- Sept 2012

Work Experience

Peking University First Hospital June 2018 –present

Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Sept 2012- June 2018

Book

Associate editor of «Key Leaders Opinionon Radiotherapywith Immunotargeted Therapies», AME Publishing Company, 2018.

Publications (1^st author)

1. Ma MW, Gao XS, Lyu F, Gu XB, Yin H, Li HZ, Li XY, Qi X, Bai Y, Chen JY, Development of a Nomogram Predicting Metastatic Disease and the Assessment of NCCN, AUA and EAU Guideline Recommendations for Bone Imaging in Prostate Cancer Patients. World Journal of Urology. Accepted


2. Ma MW, Gao XS, Yu H-l, Qi X, Sun S-q, Wang D. Cordyceps sinensis promotes the growth of prostate cancer cells. Nutrition and Cancer. 2018. 10.1080/01635581.2018.1504091


3. Ma MW, Gao XS, Gu XB, Xie M, Cui M, Zhang M, et al. The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma. World J Surg Oncol. 2018;16(1):172.


4. Ma M, Zhu H, Zhang C, Sun X, Gao X, Chen G. "Liquid biopsy"-ctDNA detection with great potential and challenges. Annals of translational medicine. 2015;3(16):235.

Disclosures: